M&A Deal Summary

FMC Acquires Epax AS

On July 24, 2013, FMC acquired life science company Epax AS from Trygg Pharma for 345M USD

Acquisition Highlights
  • This is FMC’s 2nd transaction in the Life Science sector.
  • This is FMC’s 2nd largest (disclosed) transaction.
  • This is FMC’s 1st transaction in Norway.

M&A Deal Summary
Date 2013-07-24
Target Epax AS
Sector Life Science
Buyer(s) FMC
Sellers(s) Trygg Pharma
Deal Type Divestiture
Deal Value 345M USD

Target

Epax AS

Oslo, Norway
Epax is a manufacturer of bulk marine Omega-3 oils for use in dietary supplements and functional foods. Epax was the former industrial brands division of Pronova Biocare and this divison was demerged from Pronova in December 2005.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

FMC

Philadelphia, Pennsylvania, United States
Category Company
Founded 1883
Sector Chemicals
Employees6,200
Revenue 4.5B USD (2023)
DESCRIPTION

FMC is an American chemical manufacturing company. It is a diversified chemical company serving agricultural, industrial, environmental, and consumer markets globally for more than a century with innovative solutions, applications and quality products. FMC was incorporated in 1883 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 6 of 9
Sector (Life Science) 2 of 2
Type (Divestiture) 2 of 5
Country (Norway) 1 of 1
Year (2013) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-01 GAT Microencapsulation

Ebenfurth, Austria

GAT Microencapsulation is a recognized microencapsulation specialist focusing on the stabilization of sensitive active ingredients in the fields of plant protection. GAT Microencapsulation is based in Ebenfurth, Austria.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-13 PeroxyChem

Philadelphia, Pennsylvania, United States

PeroxyChem LLC is a provider in peroxygen and adjacent chemistries with facilities in North America, Europe, and Asia. PeroxyChem manufactures high-quality products and innovative applications developed as a result of ingenuity and technical expertise. PeroxyChem LLC is based in Philadelphia, Pennsylvania.

Sell $200M

Seller(S) 1

SELLER

Trygg Pharma

Oslo, Norway
Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Trygg Pharma is a Norwegian-based 50/50 joint venture with Aker BioMarine. TPH is a manufacturer of marine-based omega-3 EPA/DHA concentrates for nutraceutical and pharmaceutical applications. EPAX, TPH’s nutraceutical division, is a long-standing leader in marine-based omega-3 EPA/DHA fatty acid concentrates for nutraceutical manufacturers and marketers, with a focus on the high concentrate segment. Trygg Pharma, TPH’s pharmaceutical division, is completing a Phase III FDA study on an omega-3-based drug candidate for hypertriglyceridemia. Trygg Pharma was founded in 2009 and is based in Oslo, Norway.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Norway) 1 of 1
Year (2013) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-03 Epax AS

Oslo, Norway

Epax is a manufacturer of bulk marine Omega-3 oils for use in dietary supplements and functional foods. Epax was the former industrial brands division of Pronova Biocare and this divison was demerged from Pronova in December 2005.

Buy -
Mergr

Product

Company

Legal